International CME for Today's Radiologist
Global Radiology CME
Neil M. Rofsky, MD, MHA, FSCBTMR, FISMRM, FACR
Scientific Program Director - Body Imaging - Mount Sinai, New York, USA
Neil Rofsky, MD, is The Dr. Charles M. and Marilyn Newman Professor and Chairman of the Department of Diagnostic, Molecular and Interventional Radiology. He is also the Senior Associate Dean of Wellness and Coaching at the Icahn School of Medicine
Mount Sinai Health Systems. He was formerly the Professor and Chair of UT Southwestern’s Department of Radiology and the Effie and Wofford Cain Distinguished Chair in Diagnostic Imaging. Dr. Rofsky also served as Director of Translational Research for the Advanced Imaging Research Center (AIRC), a collaboration of UT Southwestern and the University of Texas at Dallas. As Chair of Radiology, he also lead efforts to rapidly bring the benefits of new technologies, including some developed at the AIRC, into clinical practice.
A native of New York, Dr. Rofsky received his bachelor’s degree in biochemistry from the University of Maryland and his medical degree from New York Medical College. He then completed an internship in internal medicine at Middlesex University Hospital; a fellowship in nuclear medicine at the University of Utah Medical Center; a residency in radiology at the New York University Medical Center; and fellowships in abdominal imaging and magnetic resonance imaging at New York University Medical Center, where he was mentored by Morton Bosniak, Alec Megibow, and Jeffrey Weinreb. Dr. Rofsky also previously served as Chief of MRI at Beth Israel Deaconess Medical Center, Boston, and as Professor of Radiology at Harvard Medical School. Dr. Rofsky concentrates his research on translating innovations in magnetic resonance imaging (MRI) and spectroscopy into clinical practice. His current studies emphasize developing MRI techniques to improve detection and evaluation of prostate cancer and to better guide treatment. In his research, Dr. Rofsky seeks to apply MRI techniques such as arterial spin labeling (ASL) to measure blood flow in prostate and renal cell carcinomas. Since blood flow can reflect the viability of a tumor, these measurements can offer valuable insights into the potential aggressiveness of tumors and the effectiveness of treatments. Dr. Rofsky and his collaborators have also pioneered the use of rapid contrast-agent-enhanced three-dimensional diagnostic imaging of the abdomen. Such rapid imaging is important because it enables clinicians to obtain high-resolution 3-D images during the brief time that a patient can hold a single breath, reducing the artifacts from respiratory and other motions. Dr. Rofsky served as a member of the Board of Trustees of the Society of Computed Body Tomography and Magnetic Resonance (SCBTMR), now known as the Society of Advanced Body Imaging (SABI), and was also President of SABI in 2014-2015. He served on the Board of Trustees of the International Society for Magnetic Resonance in Medicine (ISMRM). He has authored more than 170 peer-reviewed publications, several textbooks, and presents regularly at such medical societies as the Radiological Society of North America, the ISMRM and the SCBTMR. Just recently he completed a 2 term appointment as Co-Chair for the Clinical Imaging Steering Committee of the National Cancer Institute (https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/clinical-imaging).